Patients were randomly divided into two groups : one received tamsulosin hydrochloride 0.4 mg ( Group 1 , 200 patients ) and the other tamsulosin hydrochloride 0.4 mg plus meloxicam 15 mg ( Group 2 , 200 patients ) prospectively .